Moreover, further studies including longitudinal analyses the frequency of CD4+CD25hiCD127low/−Helios+ Treg in RA patients starting TNF-α inhibitors would be of interest since this may eventually help to evaluate responses to TNF-α inhibitors therapies and prognosis in patients with RA. The gene discussed is CD4; the disease is rheumatoid arthritis.